New York Life Investment Management’s Arcosa ACA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-4,210
Closed -$361K 852
2024
Q1
$361K Sell
4,210
-1,264
-23% -$103K ﹤0.01% 1183
2023
Q4
$452K Sell
5,474
-167
-3% -$12.3K ﹤0.01% 899
2023
Q3
$406K Sell
5,641
-889
-14% -$67.4K ﹤0.01% 862
2023
Q2
$495K Sell
6,530
-1,183
-15% -$79.6K 0.01% 727
2023
Q1
$487K Sell
7,713
-2,195
-22% -$129K 0.01% 767
2022
Q4
$538K Buy
9,908
+1,062
+12% +$63.1K 0.01% 866
2022
Q3
$506K Buy
8,846
+700
+9% +$38.8K 0.01% 731
2022
Q2
$378K Buy
+8,146
New +$427K ﹤0.01% 1034

Other funds holding ACA

New York Life Investment Management's ACA Position: Q2 2024 in Review

New York Life Investment Management sold out of Arcosa (ACA) in Q2 2024, closing a stake of 4,210 shares — an estimated $361K sold.

New York Life Investment Management first reported a position in ACA in Q2 2022 and held it in 8 quarters. The position peaked at $538K in Q4 2022. 329 funds tracked by Wall St. Rank hold ACA as of Q2 2024.

  • New York Life Investment Management reported no remaining Arcosa position as of Q2 2024 after selling out during the quarter.
  • New York Life Investment Management sold 4,210 Arcosa shares in Q2 2024, an estimated $361K.
  • New York Life Investment Management first reported a position in Arcosa in Q2 2022 and held it in 8 quarters.
  • New York Life Investment Management's Arcosa position peaked at $538K in Q4 2022.
  • 329 funds tracked by Wall St. Rank held Arcosa as of Q2 2024.

Based on New York Life Investment Management's 13F filing for Q2 2024, filed 5 Aug 2024.